What analyst predict for Avid Bioservices NASDAQ:CDMO?


What analyst predict for Avid Bioservices NASDAQ:CDMO?

Avid Bioservices NASDAQ:CDMO headquartered in Alachua, Florida, United States is reporting their earnings on 09/10/2018 before the bell. Street forecast for the quarter ending March 2018 is $-0.09.

According to stock market daily analyst this is Lower then same time previous year. Avid Bioservices, reported EPS for the same quarter last year was $-0.06.



Overview of Avid Bioservices NASDAQ:CDMO

Avid Bioservices process sciences group develops the process and analytical methods needed to deliver active products that can readily transfer to cGMP manufacturing. In addition to extensive experience with platform CHO-based IgG expression, the team brings experience gained through project successes in vaccine, recombinant protein, and enzyme process development, providing the expertise you need to advance your program to the next phase.

Scale-up and GMP process conversion

Our Manufacturing Team works closely with Process Sciences, Quality, Supply Chain, and Product Sponsor to successfully transfer processes from Lab-scale to Manufacturing-scale. Process SMEs (Subject Matter Experts) stay involved throughout the life cycle of the process from development to commercial manufacturing.

Drug substance

Our cGMP facilities in Orange County, California houses manufacturing space dedicated to mammalian cell culture and is able to produce both clinical and commercial biologics. Operating both stainless steel and single use systems, we have flexibility and experience to support a wide array of projects up to 2,000L.

% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Dividend Rate